Edition:
India

Moleculin Biotech - Received A Deficiency Letter From Listing Qualifications Department Of Nasdaq


Friday, 27 Mar 2020 

March 26 (Reuters) - Moleculin Biotech Inc ::MOLECULIN BIOTECH INC - RECEIVED A DEFICIENCY LETTER FROM LISTING QUALIFICATIONS DEPARTMENT OF NASDAQ.